Famke Janssen as Jean Grey in 'X-Men: The Last Stand' 20th Century Fox Film Corp Famke Janssen is not sure what Marvel has planned for the X-Men saga but doesn’t shut the door on the idea of reprising ...

AMSTERDAM, Aug 23 (Reuters) - Johnson & Johnson's (JNJ.N), opens new tab Janssen division, which helped to develop its single-dose COVID-19 vaccine, will close much of its vaccine research and ...

As reports of COVID-19 morbidities and mortalities rose in the United States (U.S.), inequities in the healthcare landscape quickly became apparent, with cases, hospitalizations, and deaths due to the ...

Janssen, a Johnson & Johnson company, has announced positive topline results from its Phase 2b FRONTIER 1 trial evaluating JNJ-2113, a novel first-and-only oral interleukin-23 receptor antagonist ...

The US Food and Drug Administration (FDA) has approved a new cell-based therapy for blood cancer, developed by Janssen and China's Legend Biotech to treat multiple myeloma. CARVYKTI (ciltacabtagene ...

BEERSE, Belgium--(BUSINESS WIRE)--The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Today, privately held Navitor Pharmaceuticals, LLC (“Navitor”), announced that Janssen Pharmaceuticals, Inc. (“Janssen”), one of the Janssen Pharmaceutical Companies ...

Janssen, the pharma unit of J&J ($JNJ), has signed up two more therapy areas to its unique Disease Interception Accelerator (DIA) program as it continues to look for ...

Johnson & Johnson’s Janssen is ramping up its gene therapy work, forking over $100 million up front to develop MeiraGTx’s clinical-stage gene therapies for retinal diseases. It will have the worldwide ...

U.S. District Chief Judge F. Dennis Saylor IV of the District of Massachusetts ordered Janssen Biotech, a wholly owned subsidiary of Johnson & Johnson, which manufactures and sells Remicade and ...